Koszyca, B.Ellis, D.Toogood, I.Byard, R.2006-07-052006-07-051995Mycoses, 1995; 38(7-8):277-2800933-74071439-0507http://hdl.handle.net/2440/11667Pulmonary zygomycosis is an aggressive, often terminal infection that may be found in patients who are immunocompromised as a result of cytotoxic chemotherapy. Conventional treatment is by surgical debridement augmented with high-dose intravenous amphotericin B, but even with such treatment the course is usually fulminant with a high mortality rate. Recent work has suggested that the new antifungal triazole, fluconazole, may be of benefit in treating zygomycete infection. The case of a 15-year-old boy who developed pulmonary zygomycosis while on chemotherapy for acute lymphoblastic leukaemia, and who survived for 11 months with oral fluconazole therapy alone, is supportive of this proposal.enZygomycosispulmonary mycosisacute lymphoblastic leukaemiafluconazoleJournal article0030004162001995178310.1111/j.1439-0507.1995.tb00407.xA1995TF657000042-s2.0-002884159068168Ellis, D. [0000-0002-7283-4667]Byard, R. [0000-0002-0524-5942]